Advanced Stent Technologies, Inc. (AST) designs, develops and manufactures stents and stent delivery systems for the treatment of atherosclerosis at bifurcations in the coronary vasculature. Our premier product – the SLK-View™ Stent and Delivery System – treats diseased bifurcations by providing stability to the main artery while maintaining access to the side branch vessel. AST has obtained a CE Mark for the SLK-View™ Stent and Delivery System. It is now commercially available outside of the United States. In the United States, we recently began our 30-human feasibility study for the FDA under an Investigational Device Exemption (IDE). AST recently completed an Outside of the United States (OUS) 80 patient study. AST continues to pioneer the research and development of innovative devices for the treatment of complicated lesions. We are currently developing the SLK-View™ DSX™ Stent and Delivery System, a dual exchange device for the treatment of lesions at bifurcations. AST believes that we are the market leader in solutions for complicated lesions.